To investigate if ELOV4 and ELOVL6 are potential therapeutic targets in CRC treatment, the present study was designed to evaluate the effect of ELOVL4 and ELOVL6 knockdown on CRC cell viability and migration capacity. This evidence concerns the gene ELOVL6 and colorectal carcinoma.